UPDATED May 08, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$410.54 | 4.0% | 31.5% | US$3.0t | US$476.88 | PE35.4x | E12.7% | 0.7% | Software | ||
GOOGL | US$169.38 | 3.4% | 51.6% | US$2.1t | US$191.48 | PE25.4x | E12.2% | 0.5% | Media | ||
AMZN | US$188.00 | 5.0% | 70.6% | US$2.0t | US$217.51 | PE51.9x | E21.5% | n/a | Retail | ||
META | US$472.60 | 7.6% | 102.8% | US$1.2t | US$520.45 | PE26.2x | E12.2% | 0.4% | Media | ||
LLY | US$775.00 | -0.2% | 77.8% | US$700.3b | US$848.35 | PE113.7x | E27.0% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$802.00 | 1.5% | 59.4% | NT$20.8t | NT$915.41 | PE24.3x | E16.1% | 1.7% | Semiconductors | ||
AVGO | US$1,325.37 | 6.6% | 111.6% | US$603.9b | US$1,501.46 | PE53x | E23.4% | 1.6% | Semiconductors | ||
NOVO B | kr.883.20 | -1.6% | 54.7% | kr.3.9t | kr.908.65 | PE44.1x | E13.1% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$195.65 | 2.0% | 43.4% | US$550.6b | US$207.83 | PB1.8x | E-1.3% | 2.4% | Banks | ||
WMT | US$60.30 | 2.5% | 18.6% | US$488.6b | US$65.26 | PE31.3x | E10.8% | 1.4% | Consumer Retailing | ||
UNH | US$503.21 | 3.9% | 2.7% | US$460.9b | US$567.36 | PE30.1x | E19.6% | 1.5% | Healthcare | ||
XOM | US$116.15 | 0.1% | 7.8% | US$458.1b | US$132.62 | PE14x | E2.5% | 3.3% | Energy | ||
700 | HK$361.40 | 4.1% | 9.6% | HK$3.4t | HK$419.57 | PE27x | E15.1% | 0.9% | Media | ||
A005930 | ₩81,300.00 | 4.9% | 25.9% | ₩540.2t | ₩103,324.32 | PE28x | E22.8% | 1.8% | Tech | ||
PG | US$165.07 | 1.0% | 7.2% | US$391.2b | US$170.09 | PE26.2x | E7.2% | 2.4% | Household | ||
JNJ | US$148.95 | -1.5% | -7.9% | US$357.9b | US$173.26 | PE21x | E6.6% | 3.3% | Pharmaceuticals & Biotech | ||
COST | US$763.41 | 5.7% | 52.8% | US$342.1b | US$776.52 | PE49.8x | E7.5% | 0.6% | Consumer Retailing | ||
HD | US$338.83 | 2.1% | 17.2% | US$337.6b | US$384.23 | PE22.2x | E4.3% | 2.7% | Retail | ||
MRK | US$129.55 | 0.6% | 9.9% | US$330.2b | US$141.64 | PE142.3x | E24.9% | 2.4% | Pharmaceuticals & Biotech | ||
ORCL | US$117.39 | 2.4% | 20.4% | US$324.1b | US$136.92 | PE30.3x | E14.6% | 1.4% | Software | ||
600519 | CN¥1,763.97 | 3.5% | 2.3% | CN¥2.2t | CN¥2,161.67 | PE28.4x | E12.7% | 2.8% | Food, Beverage & Tobacco | ||
CVX | US$162.54 | 1.8% | 3.5% | US$299.8b | US$183.11 | PE14.8x | E2.5% | 4.0% | Energy | ||
BAC | US$37.71 | 2.1% | 38.0% | US$295.9b | US$40.08 | PB1.1x | E6.2% | 2.5% | Banks | ||
ABBV | US$160.45 | -0.8% | 9.6% | US$287.0b | US$181.55 | PE47.6x | E23.0% | 3.9% | Pharmaceuticals & Biotech |